QR-koda

Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas

Kidney cancers comprise about 3% of all new malignancies in the United States. Renal cell carcinomas (RCCs) are the most common type of renal malignancy making up about 85% of kidney cancer cases. Signs and symptoms of renal cell carcinomas can result from local tumor growth, paraneoplastic syndrome...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Robert Roskoski, Jr.
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Elsevier 2024-05-01
Ráidu:Pharmacological Research
Fáttát:
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S1043661824001257
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!